Literature DB >> 2179836

Duration of live measles vaccine-induced immunity.

L E Markowitz1, S R Preblud, P E Fine, W A Orenstein.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2179836     DOI： 10.1097/00006454-199002000-00008

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  36 in total

1.  Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine.

Authors:  M Paunio; H Peltola; M Valle; I Davidkin; M Virtanen; O P Heinonen
Journal:  J Epidemiol Community Health       Date:  1999-03       Impact factor: 3.710

2.  Measles eradication: is it in our future?

Authors:  W A Orenstein; P M Strebel; M Papania; R W Sutter; W J Bellini; S L Cochi
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

3.  Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination.

Authors:  Benjamin J Umlauf; Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Viral Immunol       Date:  2012-01-12       Impact factor: 2.257

4.  The Reemergence of Measles.

Authors:  C L Abad; N Safdar
Journal:  Curr Infect Dis Rep       Date:  2015-12       Impact factor: 3.725

Review 5.  Long-term transmission of measles virus in Central and continental Western Europe.

Authors:  S Santibanez; J M Hübschen; C P Muller; F Freymuth; M M Mosquera; M Ben Mamou; M N Mulders; K E Brown; R Myers; A Mankertz
Journal:  Virus Genes       Date:  2015-02-07       Impact factor: 2.332

6.  A million dollar measles outbreak: epidemiology, risk factors, and a selective revaccination strategy.

Authors:  S E Robertson; L E Markowitz; D A Berry; E F Dini; W A Orenstein
Journal:  Public Health Rep       Date:  1992 Jan-Feb       Impact factor: 2.792

7.  New York State's two-dose schedule for measles immunization.

Authors:  G S Birkhead; D L Morse; I J Mills; L F Novick
Journal:  Public Health Rep       Date:  1991 May-Jun       Impact factor: 2.792

8.  Antibody response to measles vaccination in Turkish children.

Authors:  N Kuyucu; U Dogru; N Akar
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

9.  Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.

Authors:  Inna G Ovsyannikova; Neelam Dhiman; Robert M Jacobson; Robert A Vierkant; Gregory A Poland
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

10.  Duration of the immune response to MMR vaccine in children of two age-different groups.

Authors:  S Li Volti; G Giammanco-Bilancia; M Grassi; R Garozzo; R Gluck; G Giammanco
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.